Citation only
via OpenAlex
Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly
Salinee Jantrapirom, Luca Lo Piccolo, Hideki Yoshida, Masamitsu Yamaguchi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2018 · ▲ 22 citations
Abstract
A 2018 study in BBA - Molecular Basis of Disease shows Ubiquilin depletion increases soluble ubiquitinated TDP-43, driving neurotoxicity in Drosophila.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.bbadis.2018.06.017
- Canonical
- link ↗
- Fetched
- 2026-06-03 MST
Cite this
APA
Jantrapirom, S., Piccolo, L.L., Yoshida, H., & Yamaguchi, M. (2018). Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly. <em>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</em>. https://doi.org/10.1016/j.bbadis.2018.06.017
Vancouver
Jantrapirom S, Piccolo LL, Yoshida H, Yamaguchi M. Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018. doi:10.1016/j.bbadis.2018.06.017.
BibTeX
@article{salinee2018Deplet,
title = {Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly},
author = {Salinee Jantrapirom and Luca Lo Piccolo and Hideki Yoshida and Masamitsu Yamaguchi},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2018},
doi = {10.1016/j.bbadis.2018.06.017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Human Molecular Genetics 2014
Open access · OA
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease
Nature Medicine 2018
Preprint · OA
The molecular landscape of glioma in patients with Neurofibromatosis 1
Antioxidants (Basel, Switzerland) 2026
Open access · OA
Biosacetalin (1,1-Diethoxyethane) Improves Healthy Lifespan in C. elegans and Rats
Free Radical Biology and Medicine 2022
Open access · OA
The role of cycloastragenol at the intersection of NRF2/ARE, telomerase, and proteasome activity
Pfizer 2015
Open access · US-GOV
A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo Controlled First-in-human Trial To Evaluate The Safety,Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06751979 After Oral Administration Of Single And Multiple Ascending Doses To Healthy Adult And Elderly Subjects
The Lancet Oncology 2014
Open access · OA